Characterizing Response to Neoadjuvant Chemotherapy in Invasive Lobular Breast Carcinoma
This study seeks to evaluate national trends in the use of NCT for ILC compared with IDC, and determine if there is a subset of ILC patients who demonstrate favorable response rates.
Source: Journal of Surgical Research - Category: Surgery Authors: Luis A. Riba, Teresa Russell, Amulya Alapati, Roger B. Davis, Ted A. James Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Ductal Carcinoma | Lobular Carcinoma | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study